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Abstract
Background: In order to interpret the results obtained from a microarray experiment, researchers often shift focus
from analysis of individual differentially expressed genes to analyses of sets of genes. These gene-set analysis (GSA)
methods use previously accumulated biological knowledge to group genes into sets and then aim to rank these
gene sets in a way that reflects their relative importance in the experimental situation in question. We suspect that
the presence of paralogs affects the ability of GSA methods to accurately identify the most important sets of genes
for subsequent research.
Results: We show that paralogs, which typically have high sequence identity and similar molecular functions, also
exhibit high correlation in their expression patterns. We investigate this correlation as a potential confounding
factor common to current GSA methods using Indygene http://www.cbio.uct.ac.za/indygene, a web tool that
reduces a supplied list of genes so that it includes no pairwise paralogy relationships above a specified sequence
similarity threshold. We use the tool to reanalyse previously published microarray datasets and determine the
potential utility of accounting for the presence of paralogs.
Conclusions: The Indygene tool efficiently removes paralogy relationships from a given dataset and we found that
such a reduction, performed prior to GSA, has the ability to generate significantly different results that often
represent novel and plausible biological hypotheses. This was demonstrated for three different GSA approaches
when applied to the reanalysis of previously published microarray datasets and suggests that the redundancy and
non-independence of paralogs is an important consideration when dealing with GSA methodologies.
Background
DNA microarray technology provides a high-throughput
tool for gene expression analysis, and has revolutionised
biological and biomedical research. The challenge of
gaining biological insight from the inherently noisy raw
expression data obtained from a microarray experiment
has been met with numerous methodologies. Initially
developed methods aim to identify individual genes
whose expression levels differ or correlate significantly
between two or more states, and typically result in a
long list of genes for follow-up analysis or assay.
Subsequently, many methods proposed have shifted
the focus from analysis of individual genes to sets of
genes typically defined by their annotations to terms in
databases such as the Gene Ontology (GO) [1], the
Kyoto Encyclopaedia of Genes and Genomes (KEGG)
[2] or the Molecular Signatures Database (MSigDB) [3].
These gene-set analysis (GSA) methods aim to rank
these sets in a way that reflects their relative contribu-
tions to the observed gene expression changes in a par-
ticular experiment. The incorporation of an independent
representation of previously accumulated biological
knowledge into the analysis has proven to be powerful
[4] and shifting the focus from individual genes to sets
of genes has also been shown to identify biological
themes more consistently across independent studies
than results from single-gene analyses [3].
GSA Methods and Tools
Using the classification system first defined by Pavladis
et al. [5], GSA methods can be separated into
two broad categories. The earliest and most popular
methods use an overrepresentation analysis (ORA)
approach, where the first step involves selecting a list of
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any medium, provided the original work is properly cited.“interesting” genes based on their differential expression
status, correlation with a phenotype or some other cri-
teria. A contingency test is then performed to determine
the functional terms or gene sets that are over- or
underrepresented in this list when compared to the list
of all genes considered in the experiment. There are
currently over 20 tools that perform this type of analy-
sis. Amongst these, a common choice of hypothesis test
is Fisher’s exact test, which is used by tools such as
GoMiner [6], EASEonline [7] and FatiGO [8]. Other
tools including CLENCH [9], GO::TermFinder [10]
GOstat [11], GoSurfer [12] and the NetAffx GO Mining
Tool [13] offer related tests based either on binomial,
normal or c
2 approximations to the hypergeometric
distribution.
Methods using the ORA approach have been widely
criticised, because they consider only the significant
genes satisfying an arbitrary threshold and information
about the continuous evidence supporting differential
expression is lost [4]. The choice of threshold for deter-
mining “interesting” genes can severely influence the
biological conclusions drawn from analyses using these
methods [14]. More fundamentally, the statistical mod-
els themselves are considered inappropriate as they take
the gene rather than the case as the sampling unit, rely-
ing on gene randomisation to assess significance. Impli-
cit in these tests is also the highly unrealistic
assumption that gene transcripts are expressed indepen-
dently [15]. Despite these flaws, ORA methods are still
used by researchers with surprising frequency.
Subsequently, a large number of methods have been
developed to address the limitations of ORA and are col-
lectively referred to as “functional class scoring” (FCS)
methods. The methods in this second category differ
from ORA in that they do not divide the data into two
distinct groups of genes, but instead provide a score
based on all genes within a particular class or sharing a
common functional annotation. One of the most widely
adopted FCS methods is Gene Set Enrichment Analysis
(GSEA) [3,16], which starts by ranking the genes in a
microarray experiment by their gene-level statistics. The
ranked gene list is then used to calculate an enrichment
score (ES) for each gene set, which reflects the tendency
of genes in a particular set to occur towards the extremes
of the list. Gene sets whose genes are non-uniformly dis-
tributed in the list are assigned a high ES and are
expected to be more related to the gene expression dif-
ferences observed. To assess the statistical significance of
the ES, GSEA uses a sample randomisation approach.
GSEA has been shown to produce interesting and bio-
logically relevant results [16], even in cases where no
genes were found to be differentially expressed after a
multiple testing correction was applied. Results from
GSEA also indicate improvements in sensitivity and
reproducibility over those obtained using ORA methods
[3]. However a number of authors have criticised the
approach for using a competitive strategy where the sig-
nificance of a particular gene set can be affected by the
presence or absence of other higher or lower ranking
gene sets [4,17].
Other FCS methods have been proposed which
improve upon GSEA and outperform this tool in terms
of power [18]. More recently a general modular frame-
work has emerged from the observation that all GSA
strategies can be separated into a number of discreet
steps enabling systematic comparisons [19]. The general
scheme of the framework consists of a gene-level analy-
sis, followed by the calculation of gene set statistics and
finally significance assessment. The latter two steps are
each motivated by a choice of null hypothesis - a factor
of crucial importance to the overall GSA procedure.
Exceptions to this structure include methods such as
Global Test [20] and a related approach called
ANCOVA Global Test [21], which model the entire
gene set directly without the presence of separate inter-
vening steps for the calculation of gene-level and gene
set statistics (see [19] for a review).
Goeman and Buhlmann [15] first described the differ-
ences between various GSA methods in terms of their
null hypotheses, where the two most common choices
are termed the “competitive null hypothesis”, H
comp
0
and the “self-contained null hypothesis”, H
self
0 .T h e i r
general formulations are given by,
HG
comp
0 :  The genes in   are as often differentially expresse ed
as the genes in G
c.
HG
self
0 :.  No genes in   are differentially expressed
where G represents the gene set of interest and G
c its
complement. ORA methods test a competitive null
hypothesis and their use of gene randomisation to deter-
mine statistical significance follows naturally from this.
On the other hand, assessing significance using sample
randomisation is the intuitive alternative for methods
testing a self-contained null hypothesis. These latter
methods avoid issues relating to the competitive scoring
of gene sets and the problematic assumptions made
when performing gene randomisation to assess statistical
significance. With these distinctions in mind, GSEA can
be viewed as a hybrid GSA method in that its choice of
a Kolmogorov-Smirnov-like statistic is motivated by a
competitive null hypothesis, whereas it determines sig-
nificance of each ES using sample randomisation. This
is offered as a reason for its low power in some
instances [15].
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statistic and significance assessment include the global
procedures mentioned above as well as SAM-GS [18],
and all make use of a self-contained null hypothesis.
The Global Test tests whether subjects (or microarray
experiments) with similar gene expression profiles have
similar class labels, using a logistic regression model.
Applied to a gene set, it tests how well the expression
profiles of the member genes are able to predict the
class labels. The Global Test is versatile in that it can be
applied in diverse microarray experimental design situa-
tions including two-class, multi-class, continuous and
survival outcome types [22]. Compared to Global Test,
ANCOVA Global Test has the roles of class labels and
gene expression profiles exchanged in the regression
model, and its authors point out that it performs better
than Global Test when strong dependencies exist
between genes.
The standard SAM procedure [23] uses a t-like statis-
tic to test whether an individual gene in a microarray
experiment is differentially expressed and was developed
in this context to stabilise small variances. SAM-GS
extends the SAM procedure to identify gene sets show-
ing significant differential expression. The null hypoth-
esis is self-contained and states that a gene set is not
differentially expressed across a two-class phenotype.
SAM-GS evaluates significance by way of sample rando-
misation, where a P-value is calculated by comparing
the test statistic to its null distribution obtained by per-
muting the microarray class labels many times. Impor-
tantly, SAM-GS was developed to detect bidirectional
gene expression changes. Therefore, a significant P-
value merely indicates that the genes in the gene set
exhibit substantial expression change between the two
phenotype classes without distinguishing between differ-
entially up- or down-regulated genes. Liu et al. [24] per-
formed a comparative evaluation of the three
aforementioned GSA methods using a simulation
experiment and three real-world microarray datasets. All
three methods display similar performance, except
SAM-GS exhibits slightly higher power with regard to
highly significant gene sets.
Other methods that fall into the category of FCS
include PathwayRF [25] and the Learner of Functional
Enrichment (LeFE) [26], which both use machine learn-
ing approaches to analyse gene expression data in terms
of gene sets. Both of these methods model the expression
data as an ensemble of decision trees (Random Forest),
an advantage of which is that they have the potential to
capture complex nonlinear relationships that may exist
between genes in a gene set. A number of methods have
also taken a systems biology approach to GSA by incor-
porating pathway topology information. Examples
include ScorePAGE [27] and Pathway-Express [28].
Motivation for Indygene
There has been a flood of GSA tools developed in recent
years, but to our knowledge no research directed at eval-
uating the effect of the presence of paralogs on results
from these analyses. Typically paralogy is inferred on the
basis of sequence similarity between genes, or sequence
or structural similarity between the proteins they encode.
Additionally it is well known that paralogs show a high
degree of functional similarity - large-scale automatic
annotations of gene products to functional terms in data-
bases such as the GO have long exploited this fact. We
show that paralogs also display high correlation in their
expression patterns. This suggests that paralogs exhibit
three-fold redundancy i.e. in sequence, expression and
f u n c t i o na n dh a sl e du st os u s p e c tt h a tp a r a l o g sm a y
influence results from GSA in an undesired manner as
these methods involve comparisons between two of these
factors. A clear example of this follows from the observa-
tion that the expression correlation of paralogs is at odds
with the assumption of gene expression independence
made by GSA methods such as ORA, which use gene
resampling to assess significance.
Gene duplication seems to be a general mechanism of
adaptation to various environmental stresses, in both
prokaryotic and eukaryotic species, and paralogs can
become fixed in a population, at least initially, as a
result of their effect on gene dosage [29]. In such cases,
the number of genes associated with a particular cellular
process is more a response to environmental conditions
or stoichiometric requirements than a reflection of the
level of coordination or complexity required within the
associated pathway or cellular process. However GSA
methods in general regard all genes that are members of
a particular gene set or annotated to a particular func-
tional term as equally important in determining the
importance of that gene set. Therefore results from
apparently statistically sound procedures, such as SAM-
GS, that avoid problematic assumptions of expression
independence are still likely to be biased by the presence
of paralogs in that this represents the inclusion of, at
worst, essentially redundant information.
The ScorePAGE algorithm [27], which scores changes
in the activity of metabolic pathways using microarray
data, seems to represent an interesting exception to this
general rule. To avoid the inclusion of redundant infor-
mation, the authors abstract the analysis away from the
level of genes to enzymes, which are the most relevant
entities, by selecting one representative gene when their
products catalyze the same enzymatic reaction. Similarly,
we argue that it is desirable to account for biases repre-
sented by the presence of redundant information in the
form of paralogs. To highlight these issues and assess
the extent of the problem, we developed the Ingygene
tool, which efficiently removes paralogy relationships
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the bias resulting from the presence of paralogs, it is
expected to at least alleviate the problems relating to
redundancy and non-independence of their expression
patterns. We applied Indygene to the reanalysis of pre-
viously published microarray datasets and our results
suggest that such a reduction, performed prior to GSA,
has the ability to generate significantly different results
often representing novel and plausible biological hypoth-
eses. This was demonstrated for GoMiner, GSEA and
SAM-GS, which together cover a substantial portion of
the GSA taxonomy, both from the point of view of the
classification of the null hypothesis, as well as the dis-
tinction made between ORA and FCS.
Results and Discussion
Coexpression of Paralogs
We used gene and protein sequence data together with
a large collection of gene expression experiments to
determine the extent to which paralogs have correlated
expression patterns using Arabidopsis thaliana as a case
study. We determined candidate paralogs in Arabidopsis
using its entire proteome and a two-step procedure
involving the all-against-all comparison of 35007 Arabi-
dopsis protein sequences from UniProtKB and the global
alignment and scoring of 982254 pairs with BLAST E-
values below a cut-off threshold of 10
-5. Rost [30] found
that 90% of protein pairs with greater than 30%
sequence identity were homologous, whereas below 25%
identity less than 10% were and below 20% identity
there is an explosion in the number of false positives.
We therefore proceed by considering only those protein
pairs with sequence identity > 20%.
After attributing gene names to all protein pairs and
removing redundant gene matches and those without
associated gene name information, 677473 gene pairs
remained. We investigated the coexpression of paralogs
using a large Arabidopsis microarray gene expression data-
s e tf r o mt h eN o t t i n g h a mA r abidopsis Stock Centre’s
(NASC) AffyWatch service [31]. Gene expression values
across multiple experiments were used to calculate corre-
lation values for each paralog pair. We were able to esti-
mate Spearman’s rank correlation coefficient for 409944
gene pairs (not all paralogs found were represented on the
microarray platform used) and Figure 1 shows the mean
expression correlation for paralogs at different levels of
protein identity. Gene expression correlation of paralogs
showed a clear tendency to increase with increasing pro-
tein sequence similarity. On average, paralogs with 90-
100% protein sequence identity have a strong correlation
(  > 05 . ) in their gene expression patterns.
As these expression correlation values are based on
over 1500 individual microarray experiments, the results
presented here are highly statistically significant and
provide evidence in support of the notion that the regu-
latory and coding sequences of paralogs tend to co-
diverge [32]. The extent of the observed correlation in
the expression patterns of paralogs also warrants further
investigation in terms of their effect on results from
microarray GSA.
Indygene Tool
The Indygene tool http://www.cbio.uct.ac.za/indygene
reduces a supplied list of genes to one without paralogy
relationships, where the goal is to proceed with GSA
thereafter. The web tool consists of a simple interface
allowing the user to submit a list of gene or Affymetrix
probe identifiers and select a protein sequence identity
threshold for paralogy (see Figure 2). Currently the fol-
lowing taxa are available for selection: Arabidopsis,
human, mouse and rat. In addition, the following Affy-
metrix microarray platforms are available: Arabidopsis
ATH1 Genome Array, Arabidopsis Genome Array,
Human Genome Focus Array, Human Genome U133
Array Plate Set, Human Genome U133 Plus 2.0 Array,
Human Genome U133 Set, Human Genome U133A 2.0
Array, Human Genome U95 Set. The ‘Output’ page pro-
vides links to the reduced gene list and log file. The for-
mer contains gene identifiers in their originally
submitted format ready for use in conjunction with any
preferred GSA tool.
The Indygene algorithm calculates paralogy relation-
ships between the genes in the user-submitted gene list,
which can be represented in a graph G as edges and
vertices respectively. Reducing a list of genes to one
without paralogy relationships is equivalent to finding a
stable set in G, which is a set of vertices (genes) that are
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Figure 1 Paralog expression correlation.M e a ne x p r e s s i o n
correlation (Spearman’s r) of gene paralogs in Arabidopsis at various
protein sequence identity levels where %ID > 20. Error bars indicate
the standard error of the estimated mean values. The values in
parentheses indicate the number of unique pairwise gene
comparisons in each case.
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by an edge (paralogy relationship). Typically such graphs
contain many stable sets of different sizes, but in view of
the cost and time involved in generating gene expres-
sion data, we are interested in obtaining the largest
stable set possible so as to retain the maximum amount
of information for further analysis. This is the optimisa-
tion version of the stable set problem, called the maxi-
mum stable set problem (MSSP), which attempts to find
the largest stable set in G. MSSP is known to be an NP-
complete problem [33] and therefore there are no effi-
cient algorithms to calculate its exact solution in a rea-
sonable amount of time.
We considered three greedy algorithms that provide
approximate solutions to the MSSP, namely GRAND,
GMAX and GMIN. If a(G) is the size of the maximum
stable set in G and d(v) is the degree of vertex v,C a r o
[34] and Wei [35] both independently showed that
() / [ ( ) ] Gd v
vV
≥+
∈ ∑11
which has subsequently been referred to as the Caro-
Wei theorem [36]. Furthermore, for a graph G with
degree bounded by Δ, Halldorsson and Radhakrishnan
[37] proved that GMIN guarantees a lower bound on
stable set size of at least 3a(G)/( Δ + 2), which is greater
than that of GMAX. The results of the practical perfor-
mance of the three algorithms when applied to gene
graphs created using randomly generated lists ranging in
length from 500 to 10000 randomly selected Arabidopsis
g e n e sa r es h o w ni nF i g u r e3a n dF i g u r e4 .B o t hG M I N
and GMAX improve on solutions from GRAND by
hundreds of genes when the graph order is high, with
GMIN finding solutions at least as large as those found
by GMAX. In terms of computational time, Figure 4
shows that GMIN is the most time-efficient algorithm.
We therefore adopted an optimised version of this algo-
rithm in the Indygene tool.
Removing paralogs leads to significantly different GSA
results
If the presence of paralogs does indeed adversely affect
results from GSA, the elimination of paralagous rela-
tionships in a gene expression dataset should lead to
significantly different GSA results. To investigate this we
used the dataset of Alonso et al. [38] who measured
genome-wide expression changes in plants in response
to ethylene. We used Indygene to determine whether
performing a paralog-reduction on this dataset prior to
GSA tends to generate results that are significantly dif-
ferent from those obtained after random reductions of
the same number of genes.
We performed GSA on the original microarray dataset
using an ORA approach (see Methods) and compared
the resulting list of GO SLIM terms from the Biological
Process ontology to that obtained after reducing the
dataset by 6126 genes using Indygene. The obtained
correlation value of τ = 0.65 quantifies the difference
between the ranking of terms in the two lists. To deter-
mine whether this difference was statistically significant
and not merely related to the removal of a large number
Figure 2 Indygene ‘Tool’ page. Indygene ‘Tool’ page showing the
form used to submit a gene list for processing.
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Monte Carlo sampling procedure (see Figure 5). When
compared to this null distribution, a nonparametric P-
value ≈ 0:007 was obtained, indicating that the presence
of paralogs can significantly affect results from GSA. In
other words, a paralog reduction as performed by Indy-
gene can result in a significantly different GSA term
ranking, not simply attributable to the reduction in the
number of genes.
Reanalysis of Previously Published Datasets
Having determined that removing paralogs significantly
alters the relative ranking of gene set results, we now
ask whether these novel results can represent plausible
hypotheses regarding the biological processes underlying
the response under study, in a way that is particular to
the paralog-reduced dataset. To this end we reanalysed
previously published gene expression datasets using
t h r e et o o l sw h i c hm a k eu s eo fd i v e r s es t a t i s t i c a lm e t h -
odologies: GoMiner, GSEA and SAM-GS. The rationale
was to establish whether performing GSA on paralog-
reduced datasets could reveal novel and biologically
relevant themes not otherwise identified. However with
respect to these comparisons, it should also be noted
that any discrepancies highlighted between different sets
of results are anecdotal and not intended to show defi-
nitive benefits or drawbacks of either approach.
Reanalysis of GoMiner Results Using Indygene
There are numerous tools that use the ORA approach,
however GoMiner was amongst the first to be developed
and has proven to be one of the most popular tools with
almost 700 academic citations to date [39]. Spira et al.
[40] used GoMiner to find terms in the GO Molecular
Function ontology that were associated with genes
expressed in the airway epithelial cells of healthy never-
smokers, and therefore also associated with these cells’
normal functioning. We repeated the analysis using the
original and paralog-reduced gene lists and terms from
the GO Biological Process ontology. Using the same P-
value cut-off of a =0 . 0 5u s e db yS p i r aet al. [40], 118
GO terms were found to be significant both before and
after reduction, but there were also additional terms
found to be significant in each case. Table 1 shows only
those terms exclusive to the results obtained from either
the original or paralog-reduced list.
A number of interesting GO biological process terms
were only found to be significant when GoMiner was
applied to the paralog-reduced dataset. Their role in the
normal functioning of airway epithelial cells seems plau-
sible given the supporting evidence in the literature. For
instance Babiker et al. [41] found that the human lung
plays an important role in maintaining ‘cholesterol home-
ostasis’ (GO:0042632) by the elimination of cholesterol as
cholestenoic acid. Also, it is well known that smoking is
associated with increased HDL cholesterol levels [42],
possibly explained by the malfunctioning of this homeo-
static process caused by exposure to tobacco smoke.
Prostaglandins are a major product of airway epithe-
lium and different types are involved in functions such
as bronchodilation and bronchoconstriction. Endogen-
ous Prostaglandin E2 (PGE2) has been found to control
the latter [43]. It is therefore not surprising that ‘prosta-
glandin metabolic process’ (GO:0006693) and its parent
Correlation of Paralog-Reduced Dataset GSA Results with Original Results (Kendall's tau)
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Page 6 of 14term ‘prostanoid metabolic process’ (GO:0006692) were
found to be overrepresented amongst the expressed
genes. Also, Mollerup et al. [44] found that estrogen
receptors are expressed in normal lung tissue in both
sexes, enabling the ‘estrogen receptor signalling pathway’
(GO:0030520) to respond to the hormone, which is
required for the promotion of lung function by the
maintenance of alveoli [45].
Two of the other remaining terms (GO:0009799
‘determination of symmetry’, GO:0009855 ‘determina-
tion of bilateral symmetry’) also seem to represent plau-
sible biological processes given the importance of airway
symmetry. These results show that performing GSA on
a paralog-reduced expression dataset using the ORA
approach can yield novel and biologically relevant terms
not otherwise identified.
Table 1 GoMiner GSA results
Original dataset: unique GSA results Reduced dataset: unique GSA results
GO:0006007 - glucose catabolic process GO:0009225 - nucleotide-sugar metabolic process
GO:0009056 - catabolic process GO:0042632 - cholesterol homeostasis
GO:0002504 - antigen processing and presentation of peptide... GO:0006890 - retrograde vesicle-mediated transport Golgi to ER
GO:0019320 - hexose catabolic process GO:0000059 - protein import into nucleus docking
GO:0046365 - monosaccharide catabolic process GO:0006692 - prostanoid metabolic process
GO:0006096 - glycolysis GO:0006693 - prostaglandin metabolic process
GO:0012501 - programmed cell death GO:0006183 - GTP biosynthetic process
GO:0019882 - antigen processing and presentation GO:0007368 - determination of left right symmetry
GO:0006915 - apoptosis GO:0008543 - fibroblast growth factor receptor signaling pathway
GO:0051258 - protein polymerization GO:0009799 - determination of symmetry
GO:0008219 - cell death GO:0009855 - determination of bilateral symmetry
GO:0016265 - death GO:0030520 - estrogen receptor signaling pathway
GO:0031529 - ruffle organization and biogenesis GO:0046039 - GTP metabolic process
GO:0048259 - regulation of receptor mediated endocytosis
GO:0045045 - secretory pathway
GO:0044275 - cellular carbohydrate catabolic process
GO:0006006 - glucose metabolic process
GO:0048193 - Golgi vesicle transport
GO:0030832 - regulation of actin filament length
GO:0007018 - microtubule-based movement
GO:0016052 - carbohydrate catabolic process
GO:0001508 - regulation of action potential
GO:0043067 - regulation of programmed cell death
GO:0006879 - iron ion homeostasis
GO:0042981 - regulation of apoptosis
GO:0007265 - Ras protein signal transduction
GO:0030032 - lamellipodium biogenesis
GO:0009894 - regulation of catabolic process
GO:0032940 - secretion by cell
GO:0007010 - cytoskeleton organization and biogenesis
GO:0040017 - positive regulation of locomotion
GO:0051272 - positive regulation of cell motility
GO:0006402 - mRNA catabolic process
GO:0006471 - protein amino acid ADP-ribosylation
GO:0008064 - regulation of actin polymerization ...
GO:0030036 - actin cytoskeleton organization ...
GO:0048468 - cell development
GO:0005996 - monosaccharide metabolic process
GO:0006996 - organelle organization and biogenesis
GoMiner GSA results indicating GO Biological Process terms significantly overrepresented amongst the genes expressed in airway epithelial cells from never-
smokers. Only those terms exclusive to the results obtained from either the original or paralog-reduced list are shown. A P-value cut-off of a = 0.05 was used to
determine significance.
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GSEA is an extremely popular tool amongst biologists
and, despite widespread criticism, has been recom-
mended for the analysis of human gene expression data
in recent reviews of GSA methods [4,46]. We compared
the differences between the results from the reanalysis
of five different GSEA gene expression datasets before
and after eliminating paralogy relationships using Indy-
gene. The five datasets cover a diverse range of topics,
namely gender-specific expression differences in lym-
phoblastoid cells, p53 status in cancer cell lines, classifi-
cation of acute leukaemias and two lung cancer
outcome studies. Subramanian et al. [3] used these data-
sets to show GSEA’s ability to detect subtle but coordi-
nated expression changes in sets of related genes
defined by MSigDB. MSigDB consists of five major col-
lections of human gene sets, but we only make use of
t w oo ft h e s e :M S i g D B : C 1 ,w h i c hc o n t a i n sg e n es e t s
based on chromosomal location and MSigDB:C2, which
contains gene sets based on common roles in meta-
bolic/signalling pathways or coregulation in response to
chemical/genetic perturbations. The results of our ana-
lyses, which were obtained using the same significance
threshold as these authors, are shown in Table 2.
The original and paralog-reduced results for the lym-
phoblast cell lines dataset were similar, with the latter
revealing one gene set enriched in males and two in
females, which did not occur with the former. Accord-
ing to MSigDB:C2, the gene set attributed to work by
Croonquist et al. [47] indicates “genes upregulated in
multiple myeloma cells exposed to the pro-proliferative
cytokine IL-6 versus those co-cultured with bone mar-
row stromal cells”. The relevance of this gene set and
the sets based on studies by Chesler et al. [48] and
Bhattacharya et al. [49] to gender-specific expression
differences is not clear. The significance of these gene
s e t sm a yb ea r t i f a c t u a la n dd u et oc o n f o u n d i n gf a c t o r s
such as a gender-biased sampling programme in these
studies.
No significantly enriched gene sets unique to the para-
log-reduced ‘p53 status’ dataset were found i.e. the one
gene set identified is shared with the original results.
However, the one significantly enriched gene set unique
to the paralog-reduced ‘acute leukaemias’ dataset corre-
sponds to the 13q14 cytogenetic location (’MSigDB:C1:
chr13q14’) containing the RB gene, which is often
deleted or translocated in patients with AML, but rarely
in ALL [50]. This evidence confirms the importance of
this gene set regarding expression differences between
acute leukaemia subclasses.
For the ‘Michigan lung cancer outcome’ study, the
paralog-reduced results include three significant gene
sets shared with the original results, but no unique sets.
The Boston counterpart, on the other hand, yielded
many significantly enriched gene sets unique to the
paralog-reduced dataset and a number of these are plau-
sible contributors to the poor outcome observed.
‘MSigDB:C2:CANCER_UNDIFFERENTIATED_ME-
TA_UP’ is a gene set comprised of 69 genes commonly
upregulated in undifferentiated cancer. Undifferentiated
cancers tend to be more malignant than well-differen-
tiated cancers, possibly explaining the association
between this gene set and a poor survival outcome.
Also, the ‘MSigDB:C2:ZELLER_MYC_UP’ and ‘MSigDB:
C2:MYC_TARGETS’ gene sets contain genes that are
up-regulated, or otherwise responsive, to Myc.T h eMyc
protein is a transcription factor that stimulates the
expression of many genes involved in cell-cycle progres-
sion. Its overexpression has also been associated with
many types of cancer [51]. Furthermore, Berns et al.
[52] and Grotzer et al. [53] found that high Myc expres-
sion is correlated with a poor outcome in patients with
breast and brain cancers respectively. It is conceivable
that a similar relationship exists in the case of lung can-
cer. Explanations for the other significantly enriched
gene sets unique to the paralog-reduced dataset are not
apparent, but could provide novel hypotheses for future
investigation.
Reanalysis of SAM-GS Results Using Indygene
To benchmark the performance of SAM-GS against
GSEA, Dinu et al. [18] reanalysed the ‘p53 status’ data-
set of Subramanian et al. [3] discussed above. They used
SAM-GS to analyse this dataset and identify MSigDB
gene sets exhibiting bi-directional expression change
across a two-class phenotype, defined by the presence or
absence of the wild-type p53 gene. The results of our
SAM-GS analysis using the original and paralog-reduced
datasets are shown in Table 3. In addition to the unique
gene sets in this table, there were 43 gene sets shared
between the two sets of results. Here we focus on the
most important gene sets satisfying the stricter signifi-
cance threshold of FDR ≤ 0.001, as the original authors’
threshold of FDR ≤ 0.01 resulted in about one hundred
significant terms in each case.
The transcription factor p53 plays an important role
in the cellular response to DNA damage. Because cells
in cancerous tissue possess mutations in their DNA, up-
regulation of p53 and other downstream ‘MSigDB:C2:
DNA_DAMAGE_SIGNALING’ g e n e si st ob ee x p e c t e d
for such cells with the wild-type. The wild-type p53 pro-
tein also has the ability to arrest cells with damaged
DNA at particular points in the cell-cycle to avoid copy-
ing of these errors and provide time for their repair
[51]. This anti-proliferative effect of wild-type p53 is evi-
dent in the significance of the ‘MSigDB:C2:SHEPARD_-
NEG_REG_OF_CELL_PROLIFERATION’ gene set,
described as containing human genes whose orthologs
Faure et al. BMC Bioinformatics 2011, 12:29
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Page 8 of 14Table 2 GSEA GSA results
Original dataset: unique GSA results Reduced dataset: unique GSA results
[1] Lymphoblast cell lines: [1] Lymphoblast cell lines:
- Enriched in males: -Enriched in males:
TGFBETA_C2_UP CROONQUIST_IL6_STROMA_UP
-Enriched in females: -Enriched in females:
CHESLER_HIGHEST_FOLD_RANGE_GENES BHATTACHARYA_ESC_UP
[2] p53 status in NCI-60 cell lines: [2] p53 status in NCI-60 cell lines:
-Enriched in p53 wild type: -Enriched in p53 wild type:
P53HYPOXIAPATHWAY
HSP27PATHWAY
MMS_HUMAN_LYMPH_HIGH_24HRS_UP
P53PATHWAY
KANNAN_P53_UP
P53_BRCA_UP
RADIATION_SENSITIVITY
[3] Acute leukaemias: [3] Acute leukaemias:
-Enriched in ALL: -Enriched in ALL:
chr13q14
[4] Lung cancer outcome (Boston study): [4] Lung cancer outcome (Boston study):
-Enriched in poor outcome: -Enriched in poor outcome:
TGFBETA_C1_UP HDACLCOLON_TSA_DN CANCER_UNDIFFERENTIATED_META_UP
MARSHALL_SPLEEN_BAL
TRNASYNTHETASES
EGF_HDMEC_UP
AMINOACYL-TRNA_BIOSYNTHESIS
ZELLER_MYC_UP
HDACI_COLON_BUT16HRS_DN
ZHAN_MULTIPLE_MYELOMA_SUBCLASSES_DIFF
MYC_TARGETS
MENSE_HYPOXIA_UP
SMITH_HTERT_UP
DOX_RESIST_GASTRIC_UP
BASSO_REGULATORY_HUBS
[5] Lung cancer outcome (Michigan study): [5] Lung cancer outcome (Michigan study):
-Enriched in poor outcome: -Enriched in poor outcome:
TGFBETA_C1_UP
HSA00010_GLYCOLYSIS_AND_GLUCONEOGENESIS
GLYCOLYSIS GLUCONEOGENESIS
MENSE_HYPOXIA_UP
VEGFPATHWAY
ROME_INSULIN_2F_UP
INSULIN-SIGNALING
BHATTACHARYA_ESC_UP
VANTVEER_BREAST_OUTCOME_GOOD_VS_POOR_DN
GLYCOLYSIS_AND_GLUCONEOGENESIS
ZUCCHI_EPITHELIAL_DN
HYPOXIA_REVIEW
GSEA results of five diverse gene expression datasets showing gene sets significantly enriched in the phenotype indicated. Functional gene sets (MSigDB:C2)
were used in all cases, except for the leukaemia dataset where cytogenetic gene sets (MSigDB:C1) were used. Only those sets exclusive to the results obtained
from either the original or paralog-reduced list are shown. A threshold of FDR ≤ 0.25 was used to determine significance.
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Page 9 of 14in zebra fish negatively regulate cell proliferation.
Another interesting gene set unique to the paralog-
reduced results is ‘MSigDB:C2:DRUG_RESISTAN-
CE_AND_METABOLISM’. The findings of Bunz et al.
[54], which seem to corroborate this result, show that
t h ep r e s e n c eo fm u t a t i o n sa f f e c t i n gp53 in human can-
cer cells renders them resistant to certain drugs used in
cancer therapy. These results show that despite the sta-
tistical validity of the procedure used in SAM-GS,
removing paralogy relationships in the data does influ-
ence the results, highlighting novel and biologically
plausible hypotheses in the form of significantly
enriched gene sets not found in the original dataset.
Although we have only performed this analysis for
SAM-GS, these results suggest that the presence of
paralogs is likely to affect similar FCS methods, poten-
tially obscuring the importance of relevant and promis-
ing gene sets for follow-up analysis.
Conclusions
GSA often represents the first attempt to make biological
sense of the data obtained from a microarray, or in fact
any high-throughput experiment, and these methods
enable the generation of hypotheses regarding the experi-
ment. Promising hypotheses are usually investigated by
means of further experimentation and therefore the accu-
racy of results from GSA has a direct impact on the
amount of time, effort, money and success associated
with future studies. We investigated the effect of paralogs
on the results from GSA as we suspect that their non-
independent expression patterns and, at worst, redundant
molecular functions represents an unwanted bias.
As expected, we found that paralogs tend to have cor-
related expression patterns and their removal signifi-
cantly affects results from GSA. The Indygene tool we
developed efficiently removes paralogy relationships
from a given dataset and we found that such a reduc-
tion, performed prior to GSA, has the ability to generate
novel and biologically plausible hypotheses not other-
wise obtained. Often the number of gene sets identified
after removing paralogs is greater than that obtained
when using the original data, suggesting that this reduc-
tion does not simply result in a reduction in the number
of significant gene sets found.
We do not consider Indygene to be a permanent solu-
tion to problems caused by paralogous. In the absence
of more sophisticated approaches, it should rather be
regarded as a tool, that can be used alongside any GSA
method, to explore the potential impact of the presence
of paralogs on the results obtained. Future GSA meth-
ods should behave in such a way that the weight of evi-
dence implicating a particular biological process based
on the coordinated expression change of the participat-
ing members is greater when they have dissimilar
sequences and distinct molecular functions. This may
warrant a Bayesian statistical approach to GSA where
the prior probability that paralogs exhibit coordinated
expression change is greater than that of unrelated
genes. Similarly, GSA methods taking a systems biologi-
cal approach should account for the uniqueness of each
gene’s functional role and relative contribution in its
associated biological pathway. Aggregating the expres-
sion response of groups of related genes with similar
functions, before performing GSA on these “metagenes”,
could be another possible approach.
Methods
Paralog Prediction
Arabidopsis thaliana protein sequences were retrieved
from the UniProt Knowlegebase (UniProtKB) [55], and
Table 3 SAM-GS GSA results
Original dataset: unique GSA results Reduced dataset: unique GSA results
APOPTOSIS ADIP_VS_FIBRO_DN
APOPTOSIS-GENMAPP BCNU_GLIOMA_MGMT_48HRS_UP
APOPTOSIS_KEGG BRCA1_SW480_DN
CELLCYCLEPATHWAY BREAST_CANCER_ESTROGEN_SIGNALING
CHEMICALPATHWAY DAC_PANC50_UP
FSH_HUMAN_GRANULOSA_UP DNA_DAMAGE_SIGNALING
G1PATHWAY DRUG_RESISTANCE_AND_METABOLISM
HSA05219_BLADDER_CANCER G2PATHWAY
HSP27PATHWAY HSA05040_HUNTINGTONS_DISEASE
IL4PATHWAY OXSTRES_BREASTCA_UP
P53_BRCA1_UP PARP_KO_UP
RACCYCDPATHWAY PASSERINI_APOPTOSIS
SA_FAS_SIGNALING SA_DIACYLGLYCEROL_SIGNALING SHEPARD_NEG_REG_OF_CELL_PROLIFERATION
SAM-GS results indicating functional gene sets (MSigDB:C2) significantly enriched in the expression patterns of NCI-60 cancer cell lines with wild-type p53,
compared to those of p53 mutants. Only those terms exclusive to the results obtained from either the original or paralog-reduced list are shown. A threshold of
FDR ≤ 0.001 was used to determine significance.
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Page 10 of 14candidate paralogs were identified by running an all-
against-all BLASTP (blastall search, using an expectation
value (E-value) cut-off of 10
-5 and a BLOSUM62 amino
acid substitution matrix. We subsequently obtained a
global percentage sequence identity measure (%ID) for
candidate paralogs by performing a global alignment
using an implementation of the Needleman-Wunsch
algorithm (needle program) from the EMBOSS [56]
software suite.
Calculation of Expression Correlation
We used information from UniProt entries to assign
gene names to each Arabidopsis thaliana protein pair
and removed duplicate and self-matching gene entries
(where multiple isoforms are encoded by a single gene)
from the list of candidate paralogs. We then used Affy-
metrix GeneChip (microarray) data from the Notting-
ham Arabidopsis Stock Centre’s (NASC) AffyWatch
service [31] to determine whether gene paralogs exhibit
correlation in their expression patterns. The data con-
sists of gene expression measurements from over 1500
ATH1 GeneChips used in diverse experiments. After
removal of outlier arrays, multiple array normalisation
was carried out using the GCRMA (GC robust multi-
array average) method [57]. We calculated expression
correlation values for all pairs of genes in the list using
this normalised meta-dataset. When more than one
Affymetrix probe set identifier (probeID) was available
for a particular gene, we attempted to select the most
reliable one based on probeID suffix descriptions. To
quantify gene expression correlation, we used Spear-
man’s rank correlation coefficient (Spearman’s r). For
the calculations we used a custom script and the RPy
package [58] to enable use of the necessary statistical
functions in the R Programming Language [59].
Comparison of Greedy Algorithms for the MSSP
Consider a graph G representing a list of m genes and
the paralogy relationships between them as vertices and
edges respectively. A number of graph theoretic algo-
rithms can be used to find approximate solutions to the
maximum stable set problem (MSSP) applied to G.W e
evaluated three such algorithms: GRAND, GMAX and
GMIN, all of which use a greedy strategy. The simplest
algorithm, GRAND, randomly removes vertices with
non-zero degree until the resulting sub-graph is stable.
GMAX is similar to GRAND, however instead of ran-
domly removing vertices, a vertex of maximum degree
is removed at each step. GMIN differs from the preced-
ing two algorithms in that it selects a vertex of mini-
mum degree to retain at each step. The selected vertex
and all of its adjacent vertices are then removed from
the remaining graph. The process is repeated until G
becomes empty and the retained vertices form a stable
set. See Figure 6 for a comparison of the GRAND,
GMAX and GMIN algorithms using toy examples.
To evaluate the performance of these algorithms we
implemented them using custom Python scripts and
applied them to real-world data relevant to the intended
application. The data comprised lists ranging in length
from 500 to 10000 randomly selected Arabidopsis genes
and we indicated paralogy relationships between gene
pairs if their pre-calculated global protein sequence
identity was > 20%. We ran each algorithm 10 times on
each dataset and recorded the resulting stable set sizes
and computation times in each case.
Indygene
The Indygene front-end consists of a web application
that was developed using the Web.Py framework [60].
The input to the Indygene back-end processing system
is a job file, which contains the user-inputted gene list
and other meta-information including the organism
name, gene identifier type, timestamp and user details.
If necessary, Affymetrix probe set data is used to con-
vert microarray probeIDs to their corresponding gene
Figure 6 Comparison of three greedy algorithms for the MSSP
using a toy example. A simulated graph G representing the
paralogy relationships between 14 genes serves as input to each
algorithm considered: GRAND, GMAX, GMIN. The final stable set of
genes as well as the resulting graphs after two initial iterations are
shown. Each iteration of GRAND consists of the removal of a
random vertex (gene) whereas GMAX removes a vertex of
maximum degree. This is repeated until no edges remain and the
resulting set of genes is stable. GMIN selects a vertex of minimum
degree to retain during each iteration and all adjacent vertices are
removed. The process is repeated until G becomes empty and the
retained vertices form a stable set.
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Page 11 of 14names. The gene names are then compared with each
other and with information from UniProtKB to ensure
that each gene name/symbol is valid and unique.
Pre-computed protein similarity information for a
selected set of organisms is used to construct an adja-
cency list representation of the gene graph. This data
together with a user-selected %ID paralog cut-off is
used to determine whether an edge exists between two
genes in the graph. The greedy GMIN algorithm is then
used to reduce the gene graph to a subset of vertices
such that no edges remain. Finally, this solution is used
to construct a stable, or sequence-independent, gene list
file that can be downloaded by the user via the user
interface.
Statistical Significance of GSA Results Using Indygene
Alonso et al. [38] used the Affymetrix GeneChip plat-
form to examine the gene expression patterns in Arabi-
dopsis seedlings and apices, and determined 628 genes
whose expression levels were significantly altered after
treatment with exogenous ethylene. Similarly to these
authors, we performed GSA on this dataset using Fish-
er’s exact test to rank terms in the GO Biological Pro-
cess ontology by their overrepresentation in these genes
compared to the rest of the genes on the microarray.
Apart from issues related to this method’s assumption
that genes are expressed independently, Alexa et al. [61]
noted that the complex structure of the GO also intro-
duces dependencies among GO terms in the DAG. At
present there is no consensus on the most appropriate
way to deal with this issue when performing GSA, so to
circumvent it we restricted our analysis to Plant GO
SLIM terms.
We then used Indygene to remove pair-wise paralogy
relationships with protein sequence identity > 30% and
repeated the above GSA. To quantify the differences
between the two resulting ordered lists of GO terms i.e.
before and after the reduction, we used a ranked corre-
lation measure (Kendall’s τ). Although researchers nor-
mally focus on the few statistically significant or highly
ranked GO terms towards the top of the list, we consid-
ered the entire list so as to incorporate information
about the change in relative ranking of all GO terms.
We determined the statistical significance of this dif-
ference by comparing the above correlation test statis-
tic to the null distribution of correlation values
resulting from all possible similar-sized gene reduc-
tions i.e. a randomisation test. Because the number of
distinct gene reductions was prohibitively large we
used Monte Carlo sampling, which considers a fixed
number of randomly generated reductions instead of
enumerating all possibilities. One thousand random
‘samples’ were used to generate an estimate of the cor-
relation null distribution.
Reanalysis of GSA Results Using Indygene
We reanalysed previously published gene expression
datasets used by the authors of GoMiner, GSEA and
SAM-GS to demonstrate the utility of their proposed
GSA methods. We selected these three tools, each
representing one of the three major categories of GSA
methods discussed, to determine Indygene’su s e f u l n e s s
across a broad range of methods. Using the original
datasets we compared the GSA results obtained before
and after removing paralogy relationships with protein
sequence identity > 30% using Indygene.
Using GoMiner, we reanalysed the Common Variable
Immune Deficiency (CVID) gene expression dataset
published by Zeeberg et al. [62]. The authors used cus-
tom microarrays to measure the gene expression
response to CD3 and CD28 antigens/antibodies in per-
ipheral blood mononuclear cells (PBMC) from one
CVID patient and six healthy donors. By comparisons to
the healthy donor controls, they identified 57 genes that
were significantly differentially expressed in the cells
from the CVID patient. Using this information, we sub-
mitted the original and paralog-reduced gene lists for
analysis using the High-Throughput GoMiner web inter-
face. We also used GoMiner to reanalyse the human air-
way epithelial cell transcriptome dataset of Spira et al.
[40]. The study involved the gene expression profiling of
epithelial cell samples obtained at bronchoscopy from
85 subjects, 23 of which were healthy and had never
smoked. The authors identified 2382 genes that were
expressed in all of these healthy never-smokers. To find
GO Biological Process terms enriched in these genes,
we once again used the High-Throughput GoMiner web
interface to submit the original and paralog-reduced
gene lists for GSA.
Using the Java GSEA Desktop Application, we reana-
lysed the five different gene expression datasets covered
in the article by Subramanian et al. [3]. The first dataset
comprised mRNA expression profiles of lymphoblastoid
cells from 15 males and 17 females, in which the
authors aimed to identify cytogenetic gene sets
(MSigDB:C1) and functional gene sets (MSigDB:C2)
enriched in either gender. The second study involved
the identification of targets of the transcription factor
p53, which regulates the cell cycle in response to various
cellular stress signals including DNA damage, thereby
suppressing tumorogenesis. They used NCI-60 cancer
cell lines to find functional gene sets (MSigDB:C2)
enriched in the expression pa t t e r n so f1 7c l a s s i f i e da s
possessing the wild-type p53 gene when compared to
that of 33 classified as carrying mutations in the gene
[63], and vice-versa. Thirdly, they used GSEA and cyto-
g e n e t i cg e n es e t s( M S i g D B : C 1) to find positions of fre-
quent chromosomal alteration in acute lymphoid
leukaemia (ALL) or acute myeloid leukaemia (AML).
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from 24 ALL patients and 24 AML patients [64]. Lastly,
datasets from two independent studies were used to
determine whether GSEA could identify functional gene
sets (MSigDB:C2) correlated with clinical outcome in
lung cancer. The Boston [65] and Michigan [66] studies
measured gene expression levels in tumour samples
from 62 and 86 patients with lung adenocarcinomas
respectively, indicating patient survival outcome as
either ‘good’ or ‘poor’.
Using R code of the SAM-GS procedure made avail-
able by Dinu et al. [18], we reanalysed the ‘p53 status’
dataset of Subramanian et al. [3] using the original and
paralog-reduced gene lists. Further details of this gene
expression dataset are as indicated above.
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